Position Statements of The Philippine Society of Allergy, Asthma and Immunology on Risk Assessment and Preventive Strategies for Hypersensitivity Reactions to Radiocontrast Media

Authors

  • Maria Carmen D. Ang, MD Chair, Drug Allergy Council
  • Vicky Wee Eng-Biñas, MD Molino Doctors Hospital, Bacoor, Cavite, Philippines
  • Michelle De Vera-De Quiroz, MD The Medical City Ortigas (Ateneo de Manila School of Medicine and Public Health), Pasig City, Philippines https://orcid.org/0000-0002-3247-6690
  • Fatima Johanna T. Santos-Ocampo, MD Makati Medical Center, Makati City, Philippines
  • Adelina P. Abarintos, MD Batangas Medical Center, Batangas City, Philippines
  • Carolyn Mae M. Abelador, MD Batangas Medical Center, Batangas City, Philippines
  • Melissa Anne R. Aguirre, MD Our Lady of Fatima Medical Center-Antipolo, Antipolo City, Philippines https://orcid.org/0009-0006-9785-5321
  • Ma. Lyn R. Benito, MD Makati Medical Center, Makati City, Philippines
  • Karol Anne Camonayan-Flor, MD Notre Dame de Chartres Hospital, Baguio City, Philippines https://orcid.org/0009-0007-8536-5330
  • Mary Jane V. Concepcion, MD Adventist Medical Center-Iligan, Iligan City, Philippines
  • Lynn Mae Dedase-Serame, MD Southern Philippines Medical Center, Davao City, Philippines
  • Phorenice D. Francisco, MD Healthway-Qualimed SJDM, San Jose del Monte, Bulacan, Philippines https://orcid.org/0000-0002-6264-0738
  • Mary Ann Jean T. Patrimonio, MD St. Paul's Hospital of Iloilo, Iloilo City, Philippines
  • Mary Grace H. Villa Toledo, MD St. Paul's Hospital of Iloilo, Iloilo City, Philippines https://orcid.org/0009-0008-5865-2251
  • Maria Bettina P. Quiambao, MD University of the Philippines - Philippine General Hospital, Manila, Philippines https://orcid.org/0000-0003-1357-0136
  • Janet C. Yamyamin, MD Davao Doctors Hospital, Davao City, Philippines
  • Venjilyn S. Villaver, MD San Juan de Dios Hospital, Pasay City, Philippines

DOI:

https://doi.org/10.70552/pjaai.26.2.18766

Keywords:

contrast media, drug hypersensitivity, anaphylaxis, premedication, skin tests, risk assessment

Abstract

*This Position Statement was developed and adopted by the Drug Allergy Council of the Philippine Journal of Allergy, Asthma and Immunology (PJAAI) on September 6, 2026. The members of the Drug Allergy Council are listed above. Dr. Maria Carmen D. Ang is the Chair of the Council.

Author Biographies

Maria Carmen D. Ang, MD, Chair, Drug Allergy Council

Corresponding author: Maria Carmen D. Ang, MD, FPCP, FPSAAI
Section of Allergy and Immunology, Department of Internal Medicine
Room 505, Medical Arts Building, San Pedro Hospital
C. Guzman St., Davao City, 8000 Philippines
E-mail: drmaricar02@gmail.com

Davao Medical School Foundation, Davao City, Philippines

San Pedro Hospital, Inc, Davao City, Philippines

Southern Philippines Medical Center, Davao City, Philippines

 

Vicky Wee Eng-Biñas, MD, Molino Doctors Hospital, Bacoor, Cavite, Philippines

Molino Doctors Hospital, Bacoor, Cavite, Philippines

Michelle De Vera-De Quiroz, MD, The Medical City Ortigas (Ateneo de Manila School of Medicine and Public Health), Pasig City, Philippines

The Medical City Ortigas (Ateneo de Manila School of Medicine and Public Health), Pasig City, Philippines

Fatima Johanna T. Santos-Ocampo, MD, Makati Medical Center, Makati City, Philippines

Makati Medical Center, Makati City, Philippines

Asian Hospital and Medical Center, Muntinlupa City, Philippines

Adelina P. Abarintos, MD, Batangas Medical Center, Batangas City, Philippines

Batangas Medical Center, Batangas City, Philippines

Mary Mediatrix Medical Center, Lipa City, Batangas, Philippines

Carolyn Mae M. Abelador, MD, Batangas Medical Center, Batangas City, Philippines

Batangas Medical Center, Batangas City, Philippines

Melissa Anne R. Aguirre, MD, Our Lady of Fatima Medical Center-Antipolo, Antipolo City, Philippines

Our Lady of Fatima Medical Center-Antipolo, Antipolo City, Philippines

Lung Center of the Philippines, Quezon City, Philippines

Ma. Lyn R. Benito, MD, Makati Medical Center, Makati City, Philippines

Makati Medical Center, Makati City, Philippines

San Juan de Dios Hospital, Pasay City, Philippines

Karol Anne Camonayan-Flor, MD, Notre Dame de Chartres Hospital, Baguio City, Philippines

Notre Dame de Chartres Hospital, Baguio City, Philippines

Pines City Doctors Hospital, Baguio City, Philippines

Baguio General Hospital and Medical Center, Baguio City, Philippines

Mary Jane V. Concepcion, MD, Adventist Medical Center-Iligan, Iligan City, Philippines

Adventist Medical Center-Iligan, Iligan City, Philippines

Lynn Mae Dedase-Serame, MD, Southern Philippines Medical Center, Davao City, Philippines

Southern Philippines Medical Center, Davao City, Philippines

Phorenice D. Francisco, MD, Healthway-Qualimed SJDM, San Jose del Monte, Bulacan, Philippines

Healthway-Qualimed SJDM, San Jose del Monte, Bulacan, Philippines

Mary Ann Jean T. Patrimonio, MD, St. Paul's Hospital of Iloilo, Iloilo City, Philippines

St. Paul's Hospital of Iloilo, Iloilo City, Philippines

Mary Grace H. Villa Toledo, MD, St. Paul's Hospital of Iloilo, Iloilo City, Philippines

St. Paul's Hospital of Iloilo, Iloilo City, Philippines

Maria Bettina P. Quiambao, MD, University of the Philippines - Philippine General Hospital, Manila, Philippines

University of the Philippines - Philippine General Hospital, Manila, Philippines

Janet C. Yamyamin, MD, Davao Doctors Hospital, Davao City, Philippines

Davao Doctors Hospital, Davao City, Philippines

Venjilyn S. Villaver, MD, San Juan de Dios Hospital, Pasay City, Philippines

San Juan de Dios Hospital, Pasay City, Philippines

University of Santo Tomas-Faculty of Medicine and Surgery, Manila, Philippines

References

1. Mahajan R, Singh P. Radiocontrast media: applications and concerns. Int J Appl Basic Med Res. 2019;9(4):191-2. https://pubmed.ncbi.nlm.nih.gov/31681540 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822330 https://doi.org/10.4103/ijabmr.IJABMR_322_19

2. Rosado Ingelmo A, Doña Diaz I, Cabañas Moreno R, et al. Clinical practice guidelines for diagnosis and management of hypersensitivity reactions to contrast media. J Investig Allergol Clin Immunol. 2016;26(3):144-55. https://pubmed.ncbi.nlm.nih.gov/27326981 https://doi.org/10.18176/jiaci.0058

3. Chiu TM, Chu SY. Hypersensitivity reactions to iodinated contrast media. Biomedicines. 2022;10(5):1036. https://pubmed.ncbi.nlm.nih.gov/35625773 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138609 https://doi.org/10.3390/biomedicines10051036

4. Cha MJ, Kang DY, Lee W, et al. Hypersensitivity reactions to iodinated contrast media: a multicenter study of 196 081 patients. Radiology. 2019;293(1):117-24. https://pubmed.ncbi.nlm.nih.gov/31478801 https://doi.org/10.1148/radiol.2019190485

5. Scherer K, Harr T, Bach S, Bircher AJ. The role of iodine in hypersensitivity reactions to radio contrast media. Clin Exp Allergy. 2010;40(3):468-75. https://pubmed.ncbi.nlm.nih.gov/20210815 https://doi.org/10.1111/j.1365-2222.2009.03361.x

6. Wulf NR, Schmitz J, Choi A, Kapusnik-Uner J. Iodine allergy: common misperceptions. Am J Health Syst Pharm. 2021;78(9):781-93. https://pubmed.ncbi.nlm.nih.gov/33547463 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929401 https://doi.org/10.1093/ajhp/zxab033

7. Vega F, Van De Ven AAJM, Van Der Molen AJ. Cross-reactivity in hypersensitivity reactions to contrast agents: new classification and guide for clinical practice. Eur Radiol. 2024;34(12):7583-8. https://pubmed.ncbi.nlm.nih.gov/38937294 https://doi.org/10.1007/s00330-024-10872-8

8. Umakoshi H, Nihashi T, Takada A, et al. Iodinated contrast media substitution to prevent recurrent hypersensitivity reactions: a systematic review and meta-analysis. Radiology. 2022;305(2):341-9. https://pubmed.ncbi.nlm.nih.gov/35852428 https://doi.org/10.1148/radiol.220370

9. DrugBank. Barium sulfate. DrugBank; 2025. https://go.drugbank.com/drugs/DB11150

10. US Food and Drug Administration. Pediatric postmarketing pharmacovigilance: barium sulfate (Pediatric Postmarketing Pharmacovigilance OSE RCM #2019-570). 2019. https://www.fda.gov/media/130827/download

11. Sireci S. Clinical utility of barium sulfate products: formulation determines appropriate use. Applied Radiology. 2021;50(4). https://www.appliedradiology.com/articles/clinical-utility-of-barium-sulfate-products-formulation-determines-appropriate-use

12. Gracia Bara MT, Gallardo-Higueras A, Moreno EM, et al. Hypersensitivity to gadolinium-based contrast media. Front Allergy. 2022;3:813927. https://pubmed.ncbi.nlm.nih.gov/35386665 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974732 https://doi.org/10.3389/falgy.2022.813927

13. Pepin EW, Nordeck SM, Fetzer DT. Nontraditional uses of US contrast agents in abdominal imaging and intervention. RadioGraphics. 2022;42(6):1724-41. https://pubmed.ncbi.nlm.nih.gov/36190849 https://doi.org/10.1148/rg.220016

14. McDonald JS, Hunt CH, Kolbe AB, et al. Acute adverse events following gadolinium-based contrast agent administration: a single-center retrospective study of 281 945 injections. Radiology. 2019;292(3):620-7. https://pubmed.ncbi.nlm.nih.gov/31264948 https://doi.org/10.1148/radiol.2019182834

15. Losa F, Paoletti G, Costanzo G, et al. Hypersensitivity reactions to gadolinium-based contrast agents: update from an allergist's point of view. Clin Transl Allergy. 2025;15(8):e70086. https://pubmed.ncbi.nlm.nih.gov/40726038 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12304087 https://doi.org/10.1002/clt2.70086

16. Dispenza MC, Ditto AM. Adverse reactions to contrast media. In: Drug Allergy Testing. Elsevier; 2018:239-59. https://doi.org/10.1016/B978-0-323-48551-7.00022-5

17. Brockow K, Bonadonna P. Drug allergy in mast cell disease. Curr Opin Allergy Clin Immunol. 2012;12(4):354-60. https://pubmed.ncbi.nlm.nih.gov/22744266 https://doi.org/10.1097/ACI.0b013e328355b7cb

18. Van Der Molen AJ, Van De Ven AAJM, Vega F, et al. Hypersensitivity reactions to contrast media: part 1. Management of immediate and non-immediate hypersensitivity reactions in adults. Updated guidelines by the ESUR Contrast Media Safety Committee. Eur Radiol. 2025;35(11):6798-810. https://pubmed.ncbi.nlm.nih.gov/40425758 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12559081 https://doi.org/10.1007/s00330-025-11675-1

19. Yuan F, Zhang C, Sun M, et al. MRGPRX2 mediates immediate-type pseudo-allergic reactions induced by iodine-containing iohexol. Biomed Pharmacother. 2021;137:111323. https://pubmed.ncbi.nlm.nih.gov/33524790 https://doi.org/10.1016/j.biopha.2021.111323

20. Kumar M, Duraisamy K, Chow BKC. Unlocking the non-IgE-mediated pseudo-allergic reaction puzzle with Mas-related G-protein coupled receptor member X2 (MRGPRX2). Cells. 2021;10(5):1033. https://pubmed.ncbi.nlm.nih.gov/33925682 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146469 https://doi.org/10.3390/cells10051033

21. Zhong X, Zhao L. Hypersensitivity reactions to iodinated contrast media: potential mechanisms and clinical management. Front Med (Lausanne). 2025;12:1582072. https://pubmed.ncbi.nlm.nih.gov/40400633 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12092453 https://doi.org/10.3389/fmed.2025.1582072

22. Ali H. Regulation of human mast cell and basophil function by anaphylatoxins C3a and C5a. Immunol Lett. 2010;128(1):36-45. https://pubmed.ncbi.nlm.nih.gov/19895849 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815128 https://doi.org/10.1016/j.imlet.2009.10.007

23. Brockow K, Christiansen C, Kanny G, et al; ENDA; EAACI interest group on drug hypersensitivity. Management of hypersensitivity reactions to iodinated contrast media. Allergy. 2005;60(2):150-8. https://pubmed.ncbi.nlm.nih.gov/15647034 https://doi.org/10.1111/j.1398-9995.2005.00745.x

24. American College of Radiology, Committee on Drugs and Contrast Media. ACR Manual on Contrast Media. American College of Radiology; 2024. https://edge.sitecorecloud.io/americancoldf5f-acrorgf92a-productioncb02-3650/media/ACR/Files/Clinical/Contrast-Manual/ACR-Manual-on-Contrast-Media.pdf#page=29

25. Iyer RS, Schopp JG, Swanson JO, Thapa MM, Phillips GS. Safety essentials: acute reactions to iodinated contrast media. Can Assoc Radiol J. 2013;64(3):193-9. https://pubmed.ncbi.nlm.nih.gov/22560565 https://doi.org/10.1016/j.carj.2011.12.014

26. Wang C, Ramsey A, Lang D, et al. Management and prevention of hypersensitivity reactions to radiocontrast media: a consensus statement from the American College of Radiology and the AAAAI. J Allergy Clin Immunol Pract. 2025;13(5):1029-47. https://pubmed.ncbi.nlm.nih.gov/40332064 https://doi.org/10.1016/j.jaip.2025.01.042

27. Granata V, Cascella M, Fusco R, et al. Immediate adverse reactions to gadolinium-based MR contrast media: a retrospective analysis on 10,608 examinations. 2016:2016:3918292. https://pubmed.ncbi.nlm.nih.gov/27652261 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019936 https://doi.org/10.1155/2016/3918292

28. Ruiz de Azcárate PH, López-Sanz C, López-Raigada A, Vega F, Jiménez-Saiz R, Blanco C. Meglumine gadoterate induces immunoglobulin-independent human mast cell activation via MRGPRX2. Allergy. 2023;78(12):3255-8. https://pubmed.ncbi.nlm.nih.gov/37548384 https://doi.org/10.1111/all.15847

29. Koken G, Polat Terece S, Ertoy Karagol HI, Derinoz Guleryuz O, Bakirtas A. Unexpected early-type hypersensitivity reactions induced by rectal enema in two pediatric cases and review of the literature. Asthma Allergy Immunol. 2024:189-92. https://doi.org/10.21911/aai.2024.443

30. Laroche D, Aimone-Gastin I, Dubois F, et al. Mechanisms of severe, immediate reactions to iodinated contrast material. Radiology. 1998;209(1):183-90. https://pubmed.ncbi.nlm.nih.gov/9769830 https://doi.org/10.1148/radiology.209.1.9769830

31. Dumond P, Franck P, Morisset M, Sainte Laudy J, Kanny G, Moneret-Vautrin DA. Pre-lethal anaphylaxis to carboxymethylcellulose confirmed by identification of specific IgE -- review of the literature. Eur Ann Allergy Clin Immunol. 2009;41(6):171-6. https://pubmed.ncbi.nlm.nih.gov/20128230

32. Feczko PJ, Simms SM, Bakirci N. Fatal hypersensitivity reaction during a barium enema. AJR Am J Roentgenol. 1989;153:275-6. https://pubmed.ncbi.nlm.nih.gov/2750612 https://doi.org/10.2214/ajr.153.2.275

33. Shehadi WH. Adverse reactions to intravascularly administered contrast media: a comprehensive study based on a prospective survey. Am J Roentgenol Radium Ther Nucl Med. 1975;124(1):145-52. https://pubmed.ncbi.nlm.nih.gov/1170768 DOI: 10.2214/ajr.124.1.145

34. Bush WH, Swanson DP. Acute reactions to intravascular contrast media: types, risk factors, recognition, and specific treatment. AJR Am J Roentgenol. 1991;157(6):1153-61. https://pubmed.ncbi.nlm.nih.gov/1950858 https://doi.org/10.2214/ajr.157.6.1950858

35. Beaty AD, Lieberman PL, Slavin RG. Seafood allergy and radiocontrast media: are physicians propagating a myth? Am J Med. 2008;121(2):158.e1- e4. https://pubmed.ncbi.nlm.nih.gov/18261505 https://doi.org/10.1016/j.amjmed.2007.08.025

36. Torres MJ, Trautmann A, Böhm I, et al. Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity. Allergy. 2021;76(5):1325-39. https://pubmed.ncbi.nlm.nih.gov/33170954 https://doi.org/10.1111/all.14656

37. European Society of Urogenital Radiology. ESUR Guidelines on Contrast Media (Guideline 10.0). European Society of Urogenital Radiology; 2018. https://www.esur.org/wp-content/uploads/2022/03/ESUR-Guidelines-10_0-Final-Version.pdf

38. Yoon SH, Lee SY, Kang HR, et al. Skin tests in patients with hypersensitivity reaction to iodinated contrast media: a meta-analysis. Allergy. 2015;70(6):625-37. https://pubmed.ncbi.nlm.nih.gov/25649510 https://doi.org/10.1111/all.12589

39. Grueber HP, Helbling A, Joerg L. Skin test results and cross-reactivity patterns in IgE- and T-cell-mediated allergy to gadolinium-based contrast agents. Allergy Asthma Immunol Res. 2021;13(6):933. https://pubmed.ncbi.nlm.nih.gov/34734510 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569030 https://doi.org/10.4168/aair.2021.13.6.933

40. Bansie RD, Karim AF, Van Maaren MS, et al. Assessment of immediate and non-immediate hypersensitivity contrast reactions by skin tests and provocation tests: a review. Int J Immunopathol Pharmacol. 2021;35:20587384211015061. https://pubmed.ncbi.nlm.nih.gov/34053316 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170298 https://doi.org/10.1177/20587384211015061

41. Behzadi AH, Zhao Y, Farooq Z, Prince MR. Immediate allergic reactions to gadolinium-based contrast agents: a systematic review and meta-analysis. Radiology. 2018;286(2):471-82. https://pubmed.ncbi.nlm.nih.gov/28846495 https://doi.org/10.1148/radiol.2017162740

42. Chiriac AM, Audurier Y, Bousquet PJ, Demoly P. Clinical value of negative skin tests to gadolinium contrast agents. Allergy. 2011;66(11):1504-6. https://pubmed.ncbi.nlm.nih.gov/21854399 https://doi.org/10.1111/j.1398-9995.2011.02690.x

43. Muraro A, Worm M, Alviani C, et al. EAACI guidelines: anaphylaxis (2021 update). Allergy. 2022;77(2):357-77. https://pubmed.ncbi.nlm.nih.gov/34343358 https://doi.org/10.1111/all.15032

44. Van Der Molen AJ, Van De Ven AAJM, Vega F, et al. Hypersensitivity reactions to contrast media: part 2. Prevention of recurrent hypersensitivity reactions in adults. Updated guidelines by the ESUR Contrast Media Safety Committee. Eur Radiol. 2025;35(11):6811-25. https://pubmed.ncbi.nlm.nih.gov/40425756 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12559128 https://doi.org/10.1007/s00330-025-11676-0

45. Brockow K, Romano A, Aberer W, et al. Skin testing in patients with hypersensitivity reactions to iodinated contrast media - a European multicenter study. Allergy. 2009;64(2):234-41. https://pubmed.ncbi.nlm.nih.gov/19178403 https://doi.org/10.1111/j.1398-9995.2008.01832.x

46. Khan DA, Banerji A, Blumenthal KG, et al. Drug allergy: a 2022 practice parameter update. J Allergy Clin Immunol. 2022;150(6):1333-93. https://pubmed.ncbi.nlm.nih.gov/36122788 https://doi.org/10.1016/j.jaci.2022.08.028

47. American College of Radiology, Committee on Drugs and Contrast Media. ACR Manual on Contrast Media. American College of Radiology; 2025. https://edge.sitecorecloud.io/americancoldf5f-acrorgf92a-productioncb02-3650/media/ACR/Files/Clinical/Contrast-Manual/ACR-Manual-on-Contrast-Media.pdf

48. Abe S, Fukuda H, Tobe K, Ibukuro K. Protective effect against repeat adverse reactions to iodinated contrast medium: premedication vs changing the contrast medium. Eur Radiol. 2016;26(7):2148-54. https://pubmed.ncbi.nlm.nih.gov/26427700 https://doi.org/10.1007/s00330-015-4028-1

49. Gao H, Lu L, Saadi Neto E, et al. Biphasic, refractory, and life-threatening anaphylactic reactions to iodinated contrast media: a 10-year retrospective analysis. Ann Allergy Asthma Immunol. 2026;136(3):308-14.e1. https://pubmed.ncbi.nlm.nih.gov/41260486 https://doi.org/10.1016/j.anai.2025.11.004

50. Fan M, Zheng X, Zhu S. Research progress on desensitization of hypersensitivity reaction to iodinated contrast media. J Zhejiang Univ Sci B. 2023;52(4):526-30. https://doi.org/10.3724/zdxbyxb-2023-0220

51. Murphy A. Iodinated contrast (diagram). Radiopaedia.org. Accessed October 15, 2016. https://radiopaedia.org/cases/iodinated-contrast-diagram?lang=us

Downloads

Published

10/18/2026

How to Cite

Ang, M. C., Biñas, V., De Vera-De Quiroz, M., Santos-Ocampo, F. J., Abarintos, A., Abelador, C. M., … Villaver, V. (2026). Position Statements of The Philippine Society of Allergy, Asthma and Immunology on Risk Assessment and Preventive Strategies for Hypersensitivity Reactions to Radiocontrast Media. Philippine Journal of Allergy, Asthma and Immunology, 26(2). https://doi.org/10.70552/pjaai.26.2.18766

Issue

Vol. 26 No. 2 (2026): PJAAI (Online) December Issue

Section

Feature Articles

License

Copyright (c) 2026 Maria Carmen D. Ang, MD, Vicky Wee Eng-Biñas, MD, Michelle De Vera-De Quiroz, MD, Fatima Johanna T. Santos-Ocampo, MD, Adelina P. Abarintos, MD, Carolyn Mae M. Abelador, MD, Melissa Anne R. Aguirre, MD, Ma. Lyn R. Benito, MD, Karol Anne Camonayan-Flor, MD, Mary Jane V. Concepcion, MD, Lynn Mae Dedase-Serame, MD, Phorenice D. Francisco, MD, Mary Ann Jean T. Patrimonio, MD, Mary Grace H. Villa Toledo, MD, Maria Bettina P. Quiambao, MD, Janet C. Yamyamin, MD, Venjilyn S. Villaver, MD

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.